BDH Industries Limited
BDH.BO
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.68B
Close$
$438.52
5.8% downside
Current Fair Value
5.8% downsideOvervalued by 5.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.68 Billion |
|---|---|
| Enterprise Value | $2.68 Billion |
| Dividend Yield | $5.00 (1.07%) |
| Earnings per Share | $18.78 |
| Beta | 0.13 |
| Outstanding Shares | 5,757,300 |
Return
| Return on Equity | 15.21% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 22.89 |
|---|---|
| PEG | 46.64 |
| Price to Sales | 2.69 |
| Price to Book Ratio | 3.5 |
| Enterprise Value to Revenue | 2.69 |
| Enterprise Value to EBIT | 17.25 |
| Enterprise Value to Net Income | 22 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About BDH Industries Limited
95 employees
CEO: Jayashree G. Nair BDH Industries Limited specializes in the development and manufacture of therapeutic pharmaceutical products. Its extensive portfolio of medicines includes fentanyl citrate injection, acetaminophen oral solution, both tablet and injectab...